Skip to main content
Sign In
 

Community Newsroom

Skaggs Scholars Program


The Skaggs Scholars Program, centered at the University of Colorado and funded by a generous grant from The ALSAM Foundation, is designed to stimulate collaborative research between Colorado pharmacy faculty members and faculty members at one or more of the six other Skaggs institutions. Participating institutions include the University of Arizona College of Pharmacy, the University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Idaho State University College of Pharmacy, the University of Montana Skaggs School of Pharmacy, the Scripps Research Institute | The Skaggs Institute for Chemical Biology, and the University of Utah College of Pharmacy.

The program encourages proposal submissions from a wide range of disciplines and emphasizes high-risk/high-reward ideas that may lead to breakthrough discoveries as well as research that has the potential to accelerate the transfer of scientific research to patient care or that bring together junior investigators with established senior researchers. This year, six collaborative research grants totaling $900,000 were recently announced between our School and four Skaggs institutions (Montana, Utah and San Diego).

Grants were awarded for a two-year period effective July 1, 2017. This is the fourth round of grants that have been awarded through the program, which began in 2011. Past research has been presented during the L.S. Skaggs Biomedical Research Symposium. 


2017 Awardees

1. Assessment of Stakeholder Perspectives of the Clinical Utility of Pharmacogenomics in Solid Organ Transplantation

Principal Investigator:

Christina L. Aquilante, PharmD

Collaborating PIs: 

Jan D. Hirsch, BSPharm, Ph.D., Professor and Chair, Division of Clinical Pharmacy, University of California San Diego

Shirley Tsunoda, Pharm.D., Professor, Division of Clinical Pharmacy, University of California San Diego

 

2. America’s Dead Sea: a resource for novel anti-cancer drugs

Principal Investigator:

Rajesh Agarwal, PhD

Collaborating PI:

Dr. Jaclyn M. Winter, Assistant Professor, University of Utah College of Pharmacy


3. Development of Gold Nanoparticles for Targeting Macrophage Phenotypes in Lung Cancer

Principal Investigator:

Jared Brown, Ph.D.

Collaborating PI:

Christopher Migliaccio, Ph.D., Pharm.D. – Research Assistant Professor, Department of Biomedical and Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Montana

 

4. Ocular Toxicology of Engineered Nanomaterials

Principal Investigator:

Uday B. Kompella, PhD

Collaborating PI:

Hamid Ghandehari, PhD, Co-Director, Nano Institute of Utah, Department of Pharmaceutics and Bioengineering, University of Utah College of Pharmacy 


5. Patient-Centered Preferences for Second-Generation Multiple Sclerosis Therapies

Principal Investigator:

R. Brett McQueen, PhD

Collaborating PI:

Diana I. Brixner, RPh, PhD, Professor and Chair, University of Utah College of Pharmacy

Utah Site Co-Investigator: Kibum Kim, PhD, Post-Doctoral Fellow, University of Utah College of Pharmacy, Senior Research Analyst, University of Utah Department of Pathology

CU Co-Investigator:  Kavita V. Nair, PhD, Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

CU Co-Investigator: Jonathan D. Campbell, PhD, Associate Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

CU Co-Investigator: Timothy Vollmer, MD, Professor, University of Colorado School of Medicine


6. Elucidating the role of aryl hydrocarbon receptor in polycyclic aromatic hydrocarbons-induced skin inflammatory diseases for targeted treatment strategies

Principal Investigator:

Neera Tewari-Singh, MS, PhD

Collaborating PI:

Celine A. Beamer, PhD, Research Assistant Professor, The University of Montana, Skaggs School of Pharmacy